Arcus Biosciences annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Arcus Biosciences Debt-to-Assets Ratio Growth & History (RCUS)
Arcus Biosciences's debt-to-assets ratio was 0.17 for fiscal 2025.
View full Arcus Biosciences company overviewArcus Biosciences annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.17 | 0.04 | +25.73% |
| 2024 | 2024-12-31 | 0.14 | 0.03 | +25.12% |
| 2023 | 2023-12-31 | 0.11 | 0.02 | +17.96% |
| 2022 | 2022-12-31 | 0.09 | 0.02 | +31.34% |
| 2021 | 2021-12-31 | 0.07 | 0.05 | +204.18% |
| 2020 | 2020-12-31 | 0.02 | — | — |
Arcus Biosciences quarterly debt-to-assets ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.12 | 0.02 | +21.68% |
| Q1 2026 | 2026-03-31 | 0.11 | 0.06 | +118.37% |
| Q4 2025 | 2025-12-31 | 0.17 | 0.04 | +25.73% |
| Q3 2025 | 2025-09-30 | 0.11 | 0.07 | +146.00% |
| Q2 2025 | 2025-06-30 | 0.10 | 0.09 | +993.23% |
| Q1 2025 | 2025-03-31 | 0.05 | 0.04 | +510.10% |
| Q4 2024 | 2024-12-31 | 0.14 | 0.03 | +25.12% |
| Q3 2024 | 2024-09-30 | 0.05 | 0.04 | +513.05% |
| Q2 2024 | 2024-06-30 | 0.01 | — | — |
| Q1 2024 | 2024-03-31 | 0.01 | — | — |
| Q4 2023 | 2023-12-31 | 0.11 | 0.02 | +17.96% |
| Q3 2023 | 2023-09-30 | 0.01 | −0.08 | −91.16% |
| Q4 2022 | 2022-12-31 | 0.09 | 0.02 | +31.34% |
| Q3 2022 | 2022-09-30 | 0.09 | 0.02 | +38.83% |
| Q2 2022 | 2022-06-30 | 0.08 | 0.02 | +41.48% |
| Q1 2022 | 2022-03-31 | 0.07 | 0.06 | +373.03% |
| Q4 2021 | 2021-12-31 | 0.07 | 0.05 | +204.18% |
| Q3 2021 | 2021-09-30 | 0.06 | — | — |
| Q2 2021 | 2021-06-30 | 0.06 | — | — |
| Q1 2021 | 2021-03-31 | 0.02 | — | — |
| Q4 2020 | 2020-12-31 | 0.02 | — | — |
Arcus Biosciences debt-to-assets ratio trends
Over the last five fiscal years, Arcus Biosciences's debt-to-assets ratio increased from 0.02 to 0.17, a change of 0.15. The latest reported quarter, Q2 2026, shows 0.12.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arcus Biosciences source filings ↗Community posts
Arcus sets $17.50 share price for $250 million equity financing
Arcus Biosciences ($RCUS) priced an underwritten public offering of 14,285,715 new common shares at $17.50 apiece, targeting approximately $250 million in gross proceeds. The company is selling all of the shares, so the financing would add ...
Arcus reports additional kidney-cancer data supporting casdatifan development
Arcus Biosciences ($RCUS) released additional results from the ARC-20 program evaluating casdatifan in kidney cancer. Across pooled monotherapy cohorts involving 121 heavily pretreated patients, median overall survival was 35 months, median ...
